Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103


Physical Functioning, Pain, and Health-Related Quality of Life in Adults With Juvenile Idiopathic Arthritis: A Longitudinal 30-Year Followup Study.

Tollisen A, Selvaag AM, Aulie HA, Lilleby V, Aasland A, Lerdal A, Flatø B.

Arthritis Care Res (Hoboken). 2018 May;70(5):741-749. doi: 10.1002/acr.23327. Epub 2018 Mar 7.


Outcome in adults with juvenile idiopathic arthritis: a quality of life study.

Foster HE, Marshall N, Myers A, Dunkley P, Griffiths ID.

Arthritis Rheum. 2003 Mar;48(3):767-75.


The minimally important difference in clinical practice for patient-centered outcomes including health assessment questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma.

Sekhon S, Pope J; Canadian Scleroderma Research Group, Baron M.

J Rheumatol. 2010 Mar;37(3):591-8. doi: 10.3899/jrheum.090375. Epub 2010 Jan 15.


Longitudinal Health Status from Early Disease to Adulthood and Associated Prognostic Factors in Juvenile Idiopathic Arthritis.

Tollisen A, Selvaag AM, Aasland A, Lerdal A, Flatø B.

J Rheumatol. 2019 Mar 15. pii: jrheum.180948. doi: 10.3899/jrheum.180948. [Epub ahead of print]


Disease course, outcome, and predictors of outcome in a population-based juvenile chronic arthritis cohort followed for 17 years.

Bertilsson L, Andersson-Gäre B, Fasth A, Petersson IF, Forsblad-D'elia H.

J Rheumatol. 2013 May;40(5):715-24. doi: 10.3899/jrheum.120602. Epub 2013 Feb 15.


Patient-reported Health-related Quality of Life with apremilast for psoriatic arthritis: a phase II, randomized, controlled study.

Strand V, Schett G, Hu C, Stevens RM.

J Rheumatol. 2013 Jul;40(7):1158-65. doi: 10.3899/jrheum.121200. Epub 2013 Apr 15.


Effects of delayed-release dimethyl fumarate (DMF) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies.

Kita M, Fox RJ, Gold R, Giovannoni G, Phillips JT, Sarda SP, Kong J, Viglietta V, Sheikh SI, Okwuokenye M, Kappos L.

Clin Ther. 2014 Dec 1;36(12):1958-1971. doi: 10.1016/j.clinthera.2014.08.013. Epub 2014 Oct 12. Erratum in: Clin Ther. 2018 Mar 7;:.


Patient-reported outcomes and the association with clinical response in patients with active psoriatic arthritis treated with golimumab: findings through 2 years of a phase III, multicenter, randomized, double-blind, placebo-controlled trial.

Kavanaugh A, McInnes IB, Krueger GG, Gladman D, Beutler A, Gathany T, Mack M, Tandon N, Han C, Mease P.

Arthritis Care Res (Hoboken). 2013 Oct;65(10):1666-73. doi: 10.1002/acr.22044.


Disability and health-related quality of life in Chinese patients with rheumatoid arthritis: A cross-sectional study.

Zhou Y, Wang X, An Y, Zhang X, Han S, Li X, Wang L, Wang C, Wang Y, Yang R, Wang G, Lu X, Zhu P, Chen L, Liu J, Jin H, Liu X, Sun L, Wei P, Wang J, Chen H, Cui L, Shu R, Zhang Z, Li G, Li Z, Yang J, Li J, Jia B, Zhang F, Tao J, Lin J, Wei Q, Liu X, Ke D, Hu S, Ye C, Yang X, Li H, Huang C, Gao M, Li X, Song L, Wang Y, Wang X, Mu R, Su Y, Li Z.

Int J Rheum Dis. 2018 Sep;21(9):1709-1715. doi: 10.1111/1756-185X.13345.


A longitudinal follow-up study of physical and psychosocial health in young adults with chronic childhood arthritis.

Ostlie IL, Aasland A, Johansson I, Flatö B, Möller A.

Clin Exp Rheumatol. 2009 Nov-Dec;27(6):1039-46.


Health-related quality of life outcomes of adalimumab for patients with early rheumatoid arthritis: results from a randomized multicenter study.

Strand V, Rentz AM, Cifaldi MA, Chen N, Roy S, Revicki D.

J Rheumatol. 2012 Jan;39(1):63-72. doi: 10.3899/jrheum.101161. Epub 2011 Nov 1.


The effect of intravenous golimumab on health-related quality of life in rheumatoid arthritis: 24-week results of the phase III GO-FURTHER trial.

Bingham CO 3rd, Weinblatt M, Han C, Gathany TA, Kim L, Lo KH, Baker D, Mendelsohn A, Westhovens R.

J Rheumatol. 2014 Jun;41(6):1067-76. doi: 10.3899/jrheum.130864. Epub 2014 May 1.


Preliminary evaluation of a visual analog function scale for use in rheumatoid arthritis.

Wolfe F, Michaud K, Pincus T.

J Rheumatol. 2005 Jul;32(7):1261-6.


Quality of life in adults with juvenile-onset dermatomyositis: a case-control study.

Tollisen A, Sanner H, Flatø B, Wahl AK.

Arthritis Care Res (Hoboken). 2012 Jul;64(7):1020-7. doi: 10.1002/acr.21637.


Impact of poor mental health in adult spinal deformity patients with poor physical function: a retrospective analysis with a 2-year follow-up.

Bakhsheshian J, Scheer JK, Gum JL, Hostin R, Lafage V, Bess S, Protopsaltis TS, Burton DC, Keefe MK, Hart RA, Mundis GM Jr, Shaffrey CI, Schwab F, Smith JS, Ames CP; International Spine Study Group.

J Neurosurg Spine. 2017 Jan;26(1):116-124. doi: 10.3171/2016.5.SPINE151428. Epub 2016 Aug 19.


Factors related to health-related quality of life in ankylosing spondylitis, overall and stratified by sex.

Law L, Beckman Rehnman J, Deminger A, Klingberg E, Jacobsson LTH, Forsblad-d'Elia H.

Arthritis Res Ther. 2018 Dec 27;20(1):284. doi: 10.1186/s13075-018-1784-8.


Health-related quality of life of patients with cystic fibrosis assessed by the SF-36 questionnaire.

Uchmanowicz I, Jankowska-Polańska B, Wleklik M, Rosinczuk-Tonderys J, Dębska G.

Pneumonol Alergol Pol. 2014;82(1):10-7. doi: 10.5603/PiAP.2014.0003.


The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36.

Colangelo KJ, Pope JE, Peschken C.

J Rheumatol. 2009 Oct;36(10):2231-7. doi: 10.3899/jrheum.090193. Epub 2009 Sep 1.


Supplemental Content

Support Center